Nasopharyngeal Haemophilus and local immune response during infant respiratory syncytial virus infection - 04/03/21
Doi : 10.1016/j.jaci.2020.06.023
Meghan H. Shilts, MHS, MS a, ∗, Christian Rosas-Salazar, MD, MPH b, ∗, Kedir N. Turi, PhD c, Devi Rajan, PhD d, Seesandra V. Rajagopala, PhD a, Megan F. Patterson, MD c, Tebeb Gebretsadik, MPH e, Larry J. Anderson, MD d, R. Stokes Peebles, MD c, Tina V. Hartert, MD, MPH c 
, Suman R. Das, PhD a, f, g
, Suman R. Das, PhD a, f, g a Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
b Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tenn
c Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
d Division of Infectious Diseases, Department of Pediatrics, Emory University, Atlanta, Ga
e Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tenn
f Department of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tenn
g Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tenn
| Supported by funds from the National Institute of Allergy and Infectious Diseases (under awards U19AI095227, K24AI77930, HHSN272200900007C, R21AI142321, and U19AI110819); the National Heart, Lung, and Blood Institute (under awards K23HL148638 and R01HL146401); the Parker B. Francis Fellowship Program; the Vanderbilt Institute for Clinical and Translational Research (grant support from the National Center for Advancing Translational Sciences under award UL1TR000445); and the Vanderbilt Technologies for Advanced Genomics Core (grant support from the National Institutes of Health under awards UL1RR024975, P30CA68485, P30EY08126, and G20RR030956). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 147 - N° 3
P. 1097 - Marzo 2021 Ritorno al numero
Articolo precedente
- A deoxyribonuclease 1–like 3 genetic variant associates with asthma exacerbations
- Esther Herrera-Luis, Fabian Lorenzo-Diaz, Lesly-Anne Samedy-Bates, Celeste Eng, Jesús Villar, Jose R. Rodriguez-Santana, Esteban G. Burchard, Maria Pino-Yanes
- Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptor
- Yuhki Yanase, Yoshimi Matsuo, Shunsuke Takahagi, Tomoko Kawaguchi, Kazue Uchida, Kaori Ishii, Akio Tanaka, Daiki Matsubara, Koichiro Ozawa, Michihiro Hide
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?